Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients

(2013) Marta Toni et al.   DIABETOLOGIA

Cardiovascular Disease Risk in Young People with Type 1 Diabetes

(2012) Janet K. Snell-Bergeon et al.   Journal of Cardiovascular Translational Research

Structural arrangement of collagen fibrils in the periarterial connective tissue of the kidney: their functional relevance as a structural stabilizer against arterial pressure

(2011) Yasue Hosoyamada et al.   ANATOMICAL SCIENCE INTERNATIONAL

Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease

(2011) Trine B. Opstad et al.   CLINICA CHIMICA ACTA

Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction

(2010) Ghulam Mohammad et al.   LABORATORY INVESTIGATION

Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study

(2009) J. W. M. Nin et al.   DIABETOLOGIA

Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction

(2008) D. Kelly et al.   EUROPEAN HEART JOURNAL

Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs

(2008) Lin Lu et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

(2007) Joseph D. Raffetto et al.   BIOCHEMICAL PHARMACOLOGY